Effect of Eplerenone Treatment in Patients with Central Serous Retinopathy: A Double-Blind Randomized Clinical Trial

Effect of Eplerenone Treatment in Patients with Central Serous Retinopathy: A Double-Blind Randomized Clinical Trial

Purpose To evaluate the efficacy of eplerenone in central serous chorioretinopathy (CSCR) patients in a clinical trial design. Methods In this double-blind clinical trial, naive acute. CSCR patients were divided into two groups: treatment with eplerenone 25 mg daily in the 1st week followed by 50 mg...

Full description

Bibliographic Details
Main Authors: Mohammadreza Akhlaghi, Alireza Dehghani, Farzan Kianersi, Mohammad Reza Khalili, Mohammad Tohidi, Hamidreza Jahanbani-Ardakani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-10-01
Series:Journal of Current Ophthalmology
Subjects:
best-corrected visual acuity
central macular thickness
central serous chorioretinopathy
choroidal thickness
eplerenone
Online Access:https://journals.lww.com/10.4103/joco.joco_13_22

Internet

https://journals.lww.com/10.4103/joco.joco_13_22

Similar Items